Relmada Therapeutics Inc (NQ: RLMD )
2.830
-0.060
(-2.08%)
Streaming Delayed Price
Updated: 10:51 AM EDT, Aug 20, 2024
Add to My Watchlist
All News about Relmada Therapeutics Inc![]() ![]()
Relmada Stock Tumbles To 52-Week Low On Failed Depression Trial
October 13, 2022
Via Benzinga
![]() ![]()
Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2022
October 14, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Recap of Tuesday's Biotech Catalysts - End Of the Day Summary
August 09, 2022
Via Benzinga
![]() Via Benzinga
Global Central Nervous System Treatment Market Is Expected to Reach $166 Billion In 2028
May 26, 2022
Exposures
COVID-19
![]() ![]() ![]() ![]() ![]() ![]() ![]()
Psychedelic Drugs Market Growing as Prevalence of Mental Health Issues are Increasing Globally
February 24, 2022
Exposures
COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|